Stanley F Barshay insider trades: Merck stock sales
Companies
Where Stanley reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 5, 2010 | (MRK) | ↓ Sell | 10,000 | $37.50 | $375K | Direct | Mar 5, 2010 (0d) |
| Mar 4, 2010 | (MRK) | ↓ Sell | 20,000 | $37.05 | $741K | Direct | Mar 5, 2010 (1d) |
| Feb 26, 2010 | (MRK) | ↓ Sell | 10,000 | $36.93 | $369K | Direct | Mar 1, 2010 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Stanley F Barshay's insider trades
Stanley F Barshay is ExVP&PresConsHlthCare at Merck. Since Feb 26, 2010, Stanley has reported no open-market purchases and 3 sales worth $1.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (21 filings), option exercises (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.